Tag Archives: Raju Prasad

William Blair Downgrades Loxo Oncology (LOXO) to Hold

In a report released today, Raju Prasad from William Blair downgraded Loxo Oncology (LOXO – Research Report) to Hold. The company’s shares opened today at $233.31, close to its 52-week high of $233.90. According to TipRanks.com, Prasad is a 4-star

PTC Therapeutics (PTCT) Gets a Buy Rating from William Blair

In a report released today, Raju Prasad from William Blair maintained a Buy rating on PTC Therapeutics (PTCT – Research Report). The company’s shares opened today at $35.67. According to TipRanks.com, Prasad is a 1-star analyst with an average return

William Blair Maintains a Buy Rating on Loxo Oncology (LOXO)

In a report released today, Raju Prasad from William Blair maintained a Buy rating on Loxo Oncology (LOXO – Research Report). The company’s shares closed on Friday at $139.87. According to TipRanks.com, Prasad is a 1-star analyst with an average

Bluebird Bio (BLUE) Gets a Buy Rating from William Blair

William Blair analyst Raju Prasad maintained a Buy rating on Bluebird Bio (BLUE – Research Report) today. The company’s shares opened today at $116.86, close to its 52-week low of $102.21. According to TipRanks.com, Prasad is a 2-star analyst with

William Blair Thinks Spark Therapeutics’ Stock is Going to Recover

In a report released today, Raju Prasad from William Blair maintained a Buy rating on Spark Therapeutics (ONCE – Research Report). The company’s shares closed on Friday at $42.13, close to its 52-week low of $35.63. According to TipRanks.com, Prasad

Rocket Pharmaceuticals Inc (RCKT) Gets a Buy Rating from William Blair

In a report released today, Raju Prasad from William Blair maintained a Buy rating on Rocket Pharmaceuticals Inc (RCKT – Research Report). The company’s shares closed yesterday at $16.16. According to TipRanks.com, Prasad is a 1-star analyst with an average